Mallinckrodt To Sell BioVectra To HIG For Up To $250M
By Adam Rhodes · September 10, 2019, 12:45 PM EDT
Mallinckrodt PLC on Tuesday unveiled plans to sell its BioVectra unit to an affiliate of private equity firm HIG Capital for up to $250 million, just days after the U.K.-based pharmaceutical...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login